These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30772749)

  • 1. Risk assessment scales to predict risk of hospital treated repeat self-harm: A cost-effectiveness modelling analysis.
    Quinlivan L; Steeg S; Elvidge J; Nowland R; Davies L; Hawton K; Gunnell D; Kapur N
    J Affect Disord; 2019 Apr; 249():208-215. PubMed ID: 30772749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive accuracy of risk scales following self-harm: multicentre, prospective cohort study.
    Quinlivan L; Cooper J; Meehan D; Longson D; Potokar J; Hulme T; Marsden J; Brand F; Lange K; Riseborough E; Page L; Metcalfe C; Davies L; O'Connor R; Hawton K; Gunnell D; Kapur N
    Br J Psychiatry; 2017 Jun; 210(6):429-436. PubMed ID: 28302702
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of risk scales for predicting repeat self-harm and suicide: a multicentre, population-level cohort study using routine clinical data.
    Steeg S; Quinlivan L; Nowland R; Carroll R; Casey D; Clements C; Cooper J; Davies L; Knipe D; Ness J; O'Connor RC; Hawton K; Gunnell D; Kapur N
    BMC Psychiatry; 2018 Apr; 18(1):113. PubMed ID: 29699523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of psychosocial assessment for individuals who present to hospital following self-harm in England: A model-based retrospective analysis.
    McDaid D; Park AL; Tsiachristas A; Brand F; Casey D; Clements C; Geulayov G; Kapur N; Ness J; Waters K; Hawton K
    Eur Psychiatry; 2022 Jan; 65(1):e16. PubMed ID: 35094742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of individual and combined risk-scale items in the prediction of repetition of self-harm: multicentre prospective cohort study.
    Taylor AK; Steeg S; Quinlivan L; Gunnell D; Hawton K; Kapur N
    BJPsych Open; 2020 Dec; 7(1):e2. PubMed ID: 33261707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention - Family Therapy (SHIFT) trial.
    Cottrell DJ; Wright-Hughes A; Collinson M; Boston P; Eisler I; Fortune S; Graham EH; Green J; House AO; Kerfoot M; Owens DW; Saloniki EC; Simic M; Tubeuf S; Farrin AJ
    Health Technol Assess; 2018 Mar; 22(12):1-222. PubMed ID: 29532784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach.
    Byford S; Knapp M; Greenshields J; Ukoumunne OC; Jones V; Thompson S; Tyrer P; Schmidt U; Davidson K;
    Psychol Med; 2003 Aug; 33(6):977-86. PubMed ID: 12946082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scales for predicting risk following self-harm: an observational study in 32 hospitals in England.
    Quinlivan L; Cooper J; Steeg S; Davies L; Hawton K; Gunnell D; Kapur N
    BMJ Open; 2014 May; 4(5):e004732. PubMed ID: 24793255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and general hospital costs of self-harm across England: estimates based on the multicentre study of self-harm.
    Tsiachristas A; Geulayov G; Casey D; Ness J; Waters K; Clements C; Kapur N; McDaid D; Brand F; Hawton K
    Epidemiol Psychiatr Sci; 2020 Mar; 29():e108. PubMed ID: 32160934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm.
    Wright-Hughes A; Graham E; Farrin A; Collinson M; Boston P; Eisler I; Fortune S; Green J; House A; Owens D; Simic M; Tubeuf S; Nixon J; McCabe C; Kerfoot M; Cottrell D
    Trials; 2015 Nov; 16():501. PubMed ID: 26537599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a population-level clinical screening tool for self-harm repetition and suicide: the ReACT Self-Harm Rule.
    Steeg S; Kapur N; Webb R; Applegate E; Stewart SL; Hawton K; Bergen H; Waters K; Cooper J
    Psychol Med; 2012 Nov; 42(11):2383-94. PubMed ID: 22394511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and risk of repeat suicidal ideation and self-harm in patients who present to emergency departments with suicidal ideation or self-harm: A prospective cohort study.
    Cripps RL; Hayes JF; Pitman AL; Osborn DPJ; Werbeloff N
    J Affect Disord; 2020 Aug; 273():358-363. PubMed ID: 32560929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of joint crisis plans for people with borderline personality disorder: protocol for an exploratory randomised controlled trial.
    Moran P; Borschmann R; Flach C; Barrett B; Byford S; Hogg J; Leese M; Sutherby K; Henderson C; Rose D; Slade M; Szmukler G; Thornicroft G
    Trials; 2010 Feb; 11():18. PubMed ID: 20178572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysis.
    Tsiachristas A; McDaid D; Casey D; Brand F; Leal J; Park AL; Geulayov G; Hawton K
    Lancet Psychiatry; 2017 Oct; 4(10):759-767. PubMed ID: 28890321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sad truth about the SADPERSONS Scale: an evaluation of its clinical utility in self-harm patients.
    Saunders K; Brand F; Lascelles K; Hawton K
    Emerg Med J; 2014 Oct; 31(10):796-8. PubMed ID: 23896589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending the liaison psychiatry service in a large hospital in the UK: a before and after evaluation of the economic impact and patient care following ED attendances for self-harm.
    Opmeer BC; Hollingworth W; Marques EMR; Margelyte R; Gunnell D
    BMJ Open; 2017 Aug; 7(8):e016906. PubMed ID: 28827260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
    Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
    Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.